News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Iacocca Family Foundation and Kineta Inc. Announce New Partnership on Type 1 Diabetes Mellitus Drug Development Program


6/7/2010 11:47:07 AM

SEATTLE--(BUSINESS WIRE)--Kineta, Inc. joined with The Iacocca Family Foundation today to announce a new investment partnership to speed development of Kineta’s preclinical autoimmune drug candidate – ShK-186 - and its multiple applications to treat Type 1 diabetes mellitus.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES